MedTrace Logo

Efficacy and Safety Comparison Between SMOFlipid and Lipovenoes MCT

NCT00885781 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2011-10-17

No results posted yet for this study

Summary

Comparison of efficacy and safety of two lipid emulsion products will be performed on gastrectomy patients postsurgically.

Conditions

  • Gastrectomy
  • Malnutrition

Interventions

DRUG

lipid emulsion for TPN

1-2 g lipid emulsion /kgBW-day, for consecutive 5 days

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Ming-Tsan Lin, Dr. · Chief of General Suery department

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-04-30
Completion
2010-12-31

Countries

  • Taiwan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00885781 on ClinicalTrials.gov